Legal Status of Peptides in Finland (2026)
Research peptides are legal to purchase in Finland for scientific and laboratory use. Under the Finnish Medicines Act (Laakelaki 395/1987), substances that are not registered as medicinal products and that are sold exclusively for research purposes fall outside the authorisation and prescription regime.
The Finnish Medicines Agency (Fimea — Laakealan turvallisuus- ja kehittamiskeskus) supervises medicines in Finland. Common research peptides including BPC-157, TB-500, CJC-1295, Ipamorelin, GHK-Cu, Glutathione, and NAD+ are not listed as controlled substances under Finnish drugs legislation and do not require a permit for laboratory import from another EU member state.
Fimea Compliance and EU Intra-Community Transfers
Because ORYN dispatches from a Netherlands-based EU hub, all shipments to Finland are treated as intra-community transfers — no import declaration, no customs inspection, no Finnish VAT added at the door. Fimea's jurisdiction begins when a product is marketed as a medicine, which ORYN's research-only positioning avoids.
Key compliance points: - Products are labelled "for research purposes only" - No therapeutic claims made or implied - Certificate of Analysis (COA) accompanies every batch - GMP manufacturing + independent HPLC purity verification (>99%)
AVAILABLE PEPTIDE PENS
Delivery to Finland — PostNord and DHL
ORYN ships to all Finnish postal codes in 3–5 business days, typically 3 days to Helsinki, Espoo, Tampere, Vantaa, and Oulu, and 4–5 days to more remote Lapland addresses. Delivery is handled by Posti/PostNord for standard orders and DHL Express for time-sensitive orders.
Delivery details: - Free shipping on orders above EUR 175 - Temperature-controlled cold-chain packaging - Discreet outer box with no product descriptors - COA and ORYN research-use declaration enclosed - Tracked delivery from dispatch to doorstep